A Conversation with Dr. Lal Sadasivan of PATH and Dr. Pedro Suarez of MSH
Last year, Tuberculosis claimed the lives of 1.6 million people, and it affects the lives and livelihoods of millions more. While early diagnosis and treatment can cure and prevent the spread of TB, underreporting and under-diagnosis remains a big issue. The 2018 Global TB Report found that of the 10 million who fell ill with TB in 2017, only 6.4 million were officially recorded by national reporting systems. More dangerous yet, growing drug resistance to first-line TB drugs threatens to undermine decades of progress and make treatment both more costly and complex. Still, TB can be eradicated if governments, donors and private sector actors work together to fund and execute an accelerated response to end the TB epidemic.